EUVIMEDEUVIMED entdecken
Crossref

Devising Biocompatible, NIR‐Activated Helical Pyroptosis Agents via 𝛑‐Twisting Strategy for Promoting Antitumor Immunity

Xiaoqian Shi, Yaming Wang, Fan Qi, Hao Zhang, Yahui Cao, Xiaona Xu, Weiqing Liu, Changhua Li iD

Small · 2024

DOI: 10.1002/smll.202405496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Xiaoqian Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Functional Polymer Materials of Ministry of Education, Nan
. Hauptthemen laut MEDLINE: Pyroptosis, Biocompatible Materials. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin of China, Fundamental Research Funds for the Central Universities (Nankai University).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Specifically controlling cell pyroptosis is advantageous for oncotherapy as it allows simultaneous ablation of primary tumors and activation of immunogenicity of tumor environment. Herein, a facile and robust strategy is presented to construct efficient NIR‐activated helical pyroptosis agents (PyroAs) with negligible dark cytotoxicity. It is demonstrated that the construction of four intramolecular B‐X bonds (X = O or N) within the BODIPY chromophore enforces a significant twisting of its π‐conjugation, yielding a variety of helical H BD molecules with desired high photosensitivity and negligible dark toxicity. A robust approach is established to extend H BD into the near‐infrared (NIR) region through site‐selective incorporation of an electron‐withdrawing ester moiety. It is also proved that targeted delivery of the NIR‐activated H BD‐ER to the endoplasmic reticulum (ER) specifically activates pyroptosis pathway by equipping it with an ER‐targeting moiety. Finally, the favorable biocompatibility, excellent antitumor efficacy, and remarkable systematic immune response of this unique NIR‐activated helical PyroAs are shown in vivo, demonstrating its potential application in solid tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisBiocompatible MaterialsAnimalsHumansInfrared RaysMiceCell Line, TumorAntineoplastic AgentsBoron CompoundsNeoplasmsEndoplasmic Reticulum

Stichwörter der Autor:innen

cancer immunotherapyimmunogenic cell deathphotodynamic therapyphotosensitizerspyroptosis

Substanzen

Biocompatible MaterialsAntineoplastic AgentsBoron Compounds

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Functional Polymer Materials of Ministry of Education, Nankai University, Tianjin, 300071, China.

ORCID-Profile: Changhua Li

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin of China
  • Fundamental Research Funds for the Central Universities (Nankai University)

Zitieren

APA

Shi, X., Wang, Y., Qi, F., Zhang, H., Cao, Y., Xu, X., Liu, W., & Li, C. (2024). Devising Biocompatible, NIR‐Activated Helical Pyroptosis Agents via 𝛑‐Twisting Strategy for Promoting Antitumor Immunity. Small. https://doi.org/10.1002/smll.202405496

Vancouver

Shi X, Wang Y, Qi F, Zhang H, Cao Y, Xu X, et al. Devising Biocompatible, NIR‐Activated Helical Pyroptosis Agents via 𝛑‐Twisting Strategy for Promoting Antitumor Immunity. Small. 2024. doi:10.1002/smll.202405496

BibTeX
@article{Shi2024,
  author = {Shi, Xiaoqian and Wang, Yaming and Qi, Fan and Zhang, Hao and Cao, Yahui and Xu, Xiaona and Liu, Weiqing and Li, Changhua},
  title = {Devising Biocompatible, NIR‐Activated Helical Pyroptosis Agents via 𝛑‐Twisting Strategy for Promoting Antitumor Immunity},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202405496}
}
Kostenlos starten →